FR2317916B1 - - Google Patents

Info

Publication number
FR2317916B1
FR2317916B1 FR7621618A FR7621618A FR2317916B1 FR 2317916 B1 FR2317916 B1 FR 2317916B1 FR 7621618 A FR7621618 A FR 7621618A FR 7621618 A FR7621618 A FR 7621618A FR 2317916 B1 FR2317916 B1 FR 2317916B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7621618A
Other versions
FR2317916A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB30072/75A external-priority patent/GB1545213A/en
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of FR2317916A1 publication Critical patent/FR2317916A1/fr
Application granted granted Critical
Publication of FR2317916B1 publication Critical patent/FR2317916B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018—Esters of cycloaliphatic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7621618A 1975-07-17 1976-07-15 Analogues de prostaglandines et leurs procedes de preparation Granted FR2317916A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB30072/75A GB1545213A (en) 1975-07-17 1975-07-17 Prostaglandin analogues
GB1865176 1976-05-06

Publications (2)

Publication Number Publication Date
FR2317916A1 FR2317916A1 (fr) 1977-02-11
FR2317916B1 true FR2317916B1 (fr) 1981-01-23

Family

ID=26253511

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7621618A Granted FR2317916A1 (fr) 1975-07-17 1976-07-15 Analogues de prostaglandines et leurs procedes de preparation

Country Status (10)

Country Link
US (1) US4087620A (fr)
JP (1) JPS5922699B2 (fr)
CA (1) CA1091662A (fr)
CH (1) CH616409A5 (fr)
DE (1) DE2631894C2 (fr)
DK (1) DK318876A (fr)
FR (1) FR2317916A1 (fr)
HU (1) HU176144B (fr)
LU (1) LU75403A1 (fr)
NL (1) NL7607800A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1568371A (en) * 1975-12-03 1980-05-29 Allen & Hanburys Ltd Bicyclo(2,2,1)heptan-2-one-derivatives
GB1588196A (en) * 1977-06-14 1981-04-15 Ono Pharmaceutical Co Prostaglandin analogues
DE2834249A1 (de) * 1978-08-04 1980-02-28 Hoechst Ag Neue prostaglandinderivate in der delta 2-11-desoxy-pgf tief 2 bzw. pge tief 2 -reihe
US4312994A (en) * 1981-03-25 1982-01-26 G. D. Searle & Co. α Chain dienic prostanoic acid derivatives
US5166369A (en) * 1981-05-21 1992-11-24 American Cyanamid Company Precursors and synthesis of D1-(methyl)-16,16-(dimethyl)-11-alpha, 15-alpha, beta-dihydroxy-9-oxo-2,13,-trans, trans-prostadienoates
US4983753A (en) * 1981-05-21 1991-01-08 Floyd Jr Middleton B Precursors and synthesis of di-(methyl)-16,16-(dimethyl)-11-alpha,15-alpha beta-dihydroxy-9-oxo-2,13-trans,trans-prostadienoates
JPS6130554A (ja) * 1984-07-23 1986-02-12 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物のある特定の立体配置を有する異性体及びそれらを有効成分として含有する治療剤
ES2572755T3 (es) 2005-06-03 2016-06-02 Ono Pharmaceutical Co., Ltd. Agente para la regeneración y/o la protección de nervios
CN111263750B (zh) 2017-10-31 2022-02-25 Ａｇｃ株式会社 前列腺素衍生物的制造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034003A (en) * 1974-04-11 1977-07-05 Ono Pharmaceutical Co., Ltd. 15-Cycloalkyl-prostaglandins

Also Published As

Publication number Publication date
US4087620A (en) 1978-05-02
JPS5227753A (en) 1977-03-02
LU75403A1 (fr) 1977-04-04
NL7607800A (nl) 1977-01-19
FR2317916A1 (fr) 1977-02-11
CA1091662A (fr) 1980-12-16
CH616409A5 (fr) 1980-03-31
DK318876A (da) 1977-01-18
JPS5922699B2 (ja) 1984-05-28
DE2631894C2 (de) 1986-01-23
HU176144B (en) 1980-12-28
DE2631894A1 (de) 1977-02-10

Similar Documents

Publication Publication Date Title
JPS5430892B2 (fr)
JPS5424403B2 (fr)
JPS5426321Y2 (fr)
JPS5732799Y2 (fr)
JPS5725539Y2 (fr)
JPS5411654Y2 (fr)
JPS5529530B2 (fr)
CH598745A5 (fr)
BG22274A1 (fr)
CH594296A5 (fr)
CH593053A5 (fr)
CH598649A5 (fr)
CH592969A5 (fr)
CH592347A5 (fr)
CH591774A5 (fr)
CH591113B5 (fr)
CH590961B5 (fr)
CH590423A5 (fr)
CH590401A5 (fr)
CH589895A5 (fr)
CH588672A5 (fr)
CH586771A5 (fr)
CH583647A5 (fr)
CH576069A5 (fr)
CH595511A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse